Tempus CEO Eric Lefkofsky on using AI to revolutionize cancer treatment
Tempus founder and CEO Eric Lefkofsky joins 'The Claman Countdown' to discuss how artificial intelligence is transforming precision medicine.
We are generating necessary data to determine what treatments patients need: Tempus CEO
Tempus CEO Eric Lefkofsky discusses the company's artificial intelligence-driven precision medicine partnership with Merck on ‘The Claman Countdown.’
Employers pull back on weight-loss drug coverage
Motley Fool Asset Management chief investment strategist Bill Mann analyzes Eli Lilly's long-term growth potential amid shifts in employer coverage for weight-loss drugs on ‘The Claman Countdown.’
Moderna stock jumps amid announcement of melanoma vaccine treatment
Siebert Financial CIO Mark Malek analyzes the biotech sector bounce, Moderna's growth outlook and Nvidia's upcoming earnings report on ‘Making Money.’
GoodRx CEO details partnership with TrumpRx
GoodRx President and CEO Wendy Barnes discusses the company's partnership with TrumpRx on 'The Claman Countdown.'
AI is transforming healthcare, and the benefits are only growing: Dr. Peter Fleischut
NewYork-Presbyterian Executive Vice President Dr. Peter Fleischut discusses how AI is improving patient care, enhancing clinical decision-making, transforming anesthesia and shaping the future of medicine on 'Mornings with Maria.'
AI is the 'ultimate physician extender,' orthopedic surgeon says
Orthopedic surgeon Dr. Andrew D. Pearle discusses how AI is transforming sports medicine, the development of digital twins of joints and how the Hospital for Special Surgery (HSS) is applying AI medical technology to improve patient care.
Full spectrum of traditional healthcare will see a 'transformation' from AI, doctor says
Johns Hopkins Health System Vice President of Clinical Innovation Dr. Peter A. Najjar explains the transformative impact of AI in the medical fields and the application of the technology for oncology and cancer patients on 'Mornings with Maria.
Johns Hopkins surgeon highlights AI breakthrough that could spot pancreatic cancer before doctors
AI is accelerating drug discovery and cancer detection, but a Johns Hopkins surgeon says it is still "very early days" for measuring its full impact.
Healthcare could become an early AI 'winner,' strategist says
U.S. Bank Asset Management Group senior investment strategist Rob Haworth discusses healthcare as a lagging sector benefiting from A.I. advancements on 'The Claman Countdown.'
Pfizer CEO on primary care, GLP-1 outlook and innovation timeline
Albert Bourla, Pfizer Chairman & CEO, discusses strong performance in primary care and the game-changing Metsera acquisition for GLP-1 set to launch by 2028 on 'Mornings with Maria.'
Moderna, Merck report cancer vaccine breakthrough in melanoma trial
Moderna CEO Stéphane Bancel discusses positive cancer vaccine trial results and the impact GLP-1 drugs on 'Mornings with Maria.'
Cytokinetics' heart drug hits market after FDA approval
Cytokinetics President and CEO Robert Blum discusses the state of cardiovascular care in America on 'Mornings with Maria.'
Doctor says AI can be a 'game changer' in skin cancer detection
FOX Business' Geri Willis and 'The Big Money Show' panel discuss the application of artificial intelligence in the medical field and people flocking to the technology for health information.
AI genome sequencing could transform rare disease diagnosis: GeneDx CEO
GeneDx CEO Katherine Stueland discusses the company’s AI-driven partnership with Komodo Health, the push to speed rare disease diagnosis and GeneDx’s accelerating growth outlook.
OpenAI report shows millions turn to ChatGPT for healthcare information
'The Big Money Show' panelists weigh in on a report on people turning to ChatGPT for medical and healthcare questions.
FDA approves Novo Nordisk's weight-loss pill
Fox News senior medical analyst Dr. Marc Siegel discusses the FDA approving Novo Nordisk's Wegovy weight-loss pill, 19 states suing Health and Human Services over youth gender care and more on 'Varney & Co.'
FDA commissioner unveils major reform to fast-track drug innovation
FDA Commissioner Dr. Marty Makary joins 'Varney & Co.' to discuss the FDA's plan to cut red tape, declining men's testosterone levels and his visit to Novartis' manufacturing site.
Robotics is a 'big macro trend' in healthcare, says Medtronic CEO
Medtronic Chairman and CEO Geoffrey Martha discusses the company’s latest robotic innovation and how robotics can impact healthcare on 'The Claman Countdown.'
Pfizer wins 'fantastic deal' after $10B obesity drug fight with Novo Nordisk
Pfizer Chairman and CEO Albert Bourla joins 'Mornings with Maria' to discuss the company’s $10 billion acquisition of obesity drug startup Metsera, its competition with Novo Nordisk and his plans to expand their weight-loss drug pipeline.